IXJvsETF 2ETF Comparison
VS
ETF 2
Choose a second ETF to run a side-by-side ETF comparison with IXJ, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
IXJ performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 09/16/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | IXJ ETF 2 | -0.33%– | +7.67%– | +5.74%– | +18.28%– | +26.41%– | +25.90%– |
| Flows | IXJ ETF 2 | -– | +$290M– | -$505M– | -$256M– | -$567M– | +$23M– |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | IXJ ETF 2 | +18.51%– | +15.79%– | +14.25%– | +14.56%– |
| Max drawdown | IXJ ETF 2 | -6.30%– | -10.83%– | -18.04%– | -18.04%– |
| Max drawdown duration | IXJ ETF 2 | 22d– | 122d– | 490d– | 490d– |
Trading data
IXJ | ETF 2 | |
Last sale 9/16/2026 at 1:30 PM | $102.05 | – |
| Previous close 09/16/2026 | $102.16 | – |
| Consolidated volume 09/16/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of August 31, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
IXJ | ETF 2 | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 9/16/2026 at 1:30 PM
Live
Closed
IXJ | ETF 2 | |
|---|---|---|
| Last price | $102.05 | – |
| 1D performance | -0.11% | – |
| AuM | $4.19 B | – |
| E/R | 0.38% | – |
Characteristics
IXJ | ETF 2 | |
|---|---|---|
| Management strategy | Passive | – |
| Provider | iShares | – |
| Benchmark | S&P Global 1200 Health Care (Sector) Capped Index | – |
| N° of holdings | 110 | – |
| Asset class | - | – |
| Trailing 12m distribution yield | Join | Join |
| Inception date | November 13, 2001 | – |
| ESG | No | – |
Advertisement
Exposure
Countries
IXJ
USA
69.7%
Switzerland
10.39%
Other
19.91%
ETF 2
Sectors
IXJ
Healthcare
97.09%
Other
2.91%
ETF 2
Advertisement
Diversification
IXJ
Total weight of top 15 holdings out of 15
56.91%
ETF 2
–
Top 15 holdings
Data as of July 31, 2026
IXJ
Eli Lilly & Co.
10.27%
Johnson & Johnson
6.92%
AbbVie, Inc.
5.11%
UnitedHealth Group, Inc.
4.35%
Merck & Co., Inc.
4.06%
Roche Holding AG
3.89%
Novartis AG
3.64%
AstraZeneca PLC
3.35%
Thermo Fisher Scientific, Inc.
2.71%
Amgen, Inc.
2.65%
Abbott Laboratories
2.33%
Gilead Sciences, Inc.
2.06%
Novo Nordisk A/S
2.05%
Pfizer Inc.
1.80%
CVS Health Corp.
1.70%
ETF 2
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
Advertisement
Latest news about IXJ
Healthcare Funds on the Rise
January 9, 2024
IXJ
Healthcare Stocks Rebound
August 14, 2023
IXJ
Continued tightening of the U.S. labor market
September 23, 2022
IXJ
Advertisement
Advertisement
